Vertex Pharmaceuticals Q2 2016 Financial Results

Vertex Pharmaceuticals presents second quarter 2016 financial results and corporate strategy updates. The presentation covers CF pipeline progress including KALYDECO® and ORKAMBI® commercialization, and discusses future financial performance and development initiatives.